The effects of Morinda citrifolia L. (noni) on the immune system: Its molecular mechanisms of action

Journal of Ethnopharmacology

Volumn 115, Issue 3, 2007, Pages 502-506

  Palu, Afa K ^a   Kim, Anne Hirazumi ^a   West, Brett J ^a   Deng, Shixin ^a   Jensen, Jarakae ^a   White, Leland ^a  

^a Noni Benefits Research   (United States)

Author keywords

CB2; IFN ; IL 4; Immunomodulation; Morinda citrifolia; Rubiaceae

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 4; MORINDA CITRIFOLIA EXTRACT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; MALE; MORINDA CITRIFOLIA; MOUSE; NONHUMAN;

MORINDA CITRIFOLIA; MUS; RUBIACEAE;

EID: 37349130599     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2007.10.023     Document Type: Article

References (36)

1. Bergeron C., Page N., Joubert P., Barbeau B., Hamid Q., and Chakir J. Regulation of procollagen 1 (α1) by interleukin-4 in human bronchial fibroblasts: a possible role in airway remodelling in asthma. Clinical and Experimental Allergy 33 (2003) 1389-1397
2. Bonhaus D.W., Chang L.K., and Martin G.R. Dual activation and inhibition of adenylyl cyclise by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses. The Journal of Pharmacology and Experimental Therapeutics 287 (1998) 884-888
3. Carr M.E., Klotz J., and Bergeron M. Coumadin resistance and the vitamin supplement "Noni". American Journal of Hematology 77 (2004) 103
4. Compton D.R., Rice K.C., De Costa B.R., Razdan R.K., Melvin L.S., Johnson M.R., and Martin B.R. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. Journal of Pharmacology and Experimental Therapeutics 265 (1993) 218-226
5. Delves P.J. Chapter 12: cellular activation. In: Hames B.D., and Rickwood D. (Eds). Cellular Immunology (Labfax) (1994), Blackwell Scientific Publications, Oxford, UK 229-254
6. Di Marzo V., Bisogno T., De Petrocellis L., Melck D., Orlando P., Wagner J.A., and Unos G. Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. European Journal of Biochemistry 264 (1999) 258-267
7. European Food Safety Authority. Opinion on a request from the Commission related to the safety of noni juice (juice of the fruits of Morinda citrifolia). European Safety Authority Journal 376 (2006) 1-12
8. 2) suppresses microglial activation. Journal of Neuroinflammation 2 (2005) 29
9. European Commission, 2002. Scientific Committee on Food. Opinion of the Scientific Committee on Food on Tahitian Noni SCF/CS/NF/DOS/18 ADD 2 Final. December 11, 2002, available from http://europa.eu.int/comm/food/fs/sc/scf/out151_en.pdf.
10. Hirazumi A., and Furusawa E. An immunomodulatory polysaccharide-rich substance from the fruit juice of Morinda citrifolia (noni) with antitumour activity. Phytotherapy Researches 13 (1999) 380-387
11. Hirazumi A., Furusawa E., Chou S.C., and Hokama Y. Anticancer activity of Morinda citrifolia (noni) on intraperitoneally implanted Lewis lung carcinoma in syngeneic mice. Proceedings of the Western Pharmacology Society 37 (1994) 145-146
12. Hirazumi A., Furusawa E., Chou S.C., and Hokama Y. Immunomodulation contributes to the anticancer activity of Morinda citrifolia (noni) fruit juice. Proceedings of the Western Pharmacology Society 39 (1996) 7-9
13. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., and Pertwee R.G. Proceedings of the International Union of Pharmacology XXVII. Classification of Cannabinoid Receptors, 54 (2002) 161-202
14. 2 cannbinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proceedings of the National Academy of Sciences 100 (2003) 10529-10533
15. Kips J.C., Tournoy K.G., and Pauwels R.A. New anti-asthma therapies: suppression of the effect of interleukin (IL)-4 and IL-5. European Respiratory Journal 17 (2001) 499-506
16. Klein T.W. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nature 5 (2005) 400-411
17. Klein T.W., Lane B., Newton C.A., and Friedman H. The cannabinoid system and cytokine network. Proceedings of the Society for Experimental Biology and Medicine, 225 (2000) 1-8
18. Klein T.W., Newton C.A., Nakachi N., and Friedman H. Delta-9-Tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta-2 responses to Legionella pneumophila infection. The Journal of Immunology 164 (2000) 6461-6466
19. Malan T.P., Ibrahim M.M., Lai J., Vanderah T.W., Makriyannis A., and Porreca F. CB2 cannabinoid receptor agonists: pain relief without psychoactice effects?. Current Opinion in Pharmacology 3 (2003) 62-67
20. Massa F., Marsicano G., Hermann H., Cannich A., Monory K., Cravatt B.F., Ferri G.-L., Sibaev A., Storr M., and Lutz B. The endogenous cannabinoid system protects against colonic inflammation. The Journal of Clinical Investigation 113 (2004) 1202-1209
21. McKallip R.J., Lombard C., Fisher M., Martin B.R., Ryu S., Grant S., Nagarkatti P.S., and Nagarkatti M. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood 100 (2002) 627-634
22. Millonig G., Sadlmann S., and Vogel W. Herbal hepatotoxicity: acute hepatitis caused by a noni preparation (Morinda citrifolia). European Journal of Gastroenterology and Hepatology 17 (2005) 445-447
23. Mueller B.A., Scott M.K., Sowinski K.M., and Prag K.A. Noni juice (Morinda citrifolia): hidden potential for hyperkalemia?. American Journal of Kidney Diseases 35 (2000) 310-312
24. Munro S., Thomas K.L., and Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 (1993) 61-65
25. Nguyen V.T., and Benveniste E.N. IL-4 Activated STAT-6 inhibits IFN-gamma-induced cd40 gene expression in macrophages/microglia. The Journal of Immunology 165 (2000) 6235-6243
26. Nonaka M., Pawankar R., Fukumoto A., Ogihara N., Sakanushi A., and Yagi T. Induction of eotaxin production by interleukin-4, interleukin-13 and lipopolysaccharide by nasal fibroblasts. Clinical and Experimental Allergy 34 (2004) 804-811
27. Okano M., Satoskar A.R., Abe M., Harn Jr. D.A., Nishizaki K., Takeda Y., Yoshino T., Brombacher F., and Satoskar A.A. Interleukin-4-independent production of Th2 cytokines by nasal lymphocytes and nasal eosinophilia in murine allergic rhinitis. Allergy 55 (2000) 723-731
28. Palu A.K., Su C., Zhou B.N., and Jensen J. Morinda Citrifolia L.: a dual inhibitor of COX-2 and 5-LOX enzymes. WorldNutra 5th International Conference and Exhibition on Nutraceuticals and Functional Foods (2004) 470
29. Raduner S., Majewska A., Chen J., Xie X., Hamon J., Faller B., Altmann K., and Gertsch J. Alkylamides from Echinacea are a new class of cannabinomimetics. The Journal of Biological Chemistry 281 (2006) 14192-14206
30. 2-like cells. Clinical and Experimental Allergy 27 (1997) 488-500
31. Rinaldi-Carmona M., Calandra B., Shire D., Bouaboula M., Oustric D., Barth F., Casellas P., Ferrara P., and Le Fur G. Characterization of two cloned human CB1 cannabinoid receptor isoforms. Journal of Pharmacology and Experimental Therapeutics 278 (1996) 871-878
32. Shen M., and Thayer S.A. Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. Molecular Pharmacology 54 (1998) 459-462
33. Stadlbauer V., Fickert P., Lackner C., Schmerlaib J., Krisper P., Trauner M., and Stauber E.R. Hepatotoxicity of noni juice: report of two cases. World Journal of Gastroenterology 11 (2005) 4758-4760
34. Thomas B.F., Gilliam A.F., Burch D.F., Roche J.M., and Seltzman H.H. Comparative receptor binding analyses of cannabinoid agonists and antagonists. The Journal of Pharmacology and Experimental Therapeutics 285 (1998) 285-292
35. Wang M.Y., West B.J., Jensen C.J., Nowicki D., Su C., Palu A.K., and Anderson G. Morinda citrifolia (Noni): a literature review and recent advances in Noni research. Acta Pharmacological Sinica 12 (2002) 1127-1141
36. West B.J., Jensen C.J., Westendorf J., and White L.D. A safety review of noni fruit juice. Journal of Food Science 71 (2006) R100-R106